Medtronic cardiovascular organic growth in fiscal 2027
One-OffHealth & MedicineBusiness & Corporate12m
KalshiVerificar disponibilidadeKYC obrigatório2% de taxaDados de resolução verificadosRazoavelmente calibradoProbabilidade implícita atual
Above 10% 41%Líder entre 6 opções
Qualidade do mercado
25 / 100
Baixa qualidadeVolume 24h
—
Liquidez
344,2 €
Baixa liquidezSpread
10.0 pt
Spread amploDados do mercado
Atualizado há 10 minutos
7/08/26, 19:3031/08/27, 4:00
Tendências
0%
0%
0%
0%
0%
Regras
If Medtronic plc reports Above 6% cardiovascular organic revenue growth in fiscal 2027, then the market resolves to Yes.
Liquida via:Fiscal.ai
- This market refers to the annual figure reported in Medtronic plc's full fiscal year or Q4 earnings release.
- Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company.
- All trademarks, logos, and brand names are the property of their respective owners.
- If Medtronic plc reports Above 7% cardiovascular organic revenue growth in fiscal 2027, then the market resolves to Yes.
- If Medtronic plc reports Above 8% cardiovascular organic revenue growth in fiscal 2027, then the market resolves to Yes.
Perguntas frequentes
- Quais são as probabilidades atuais de Medtronic cardiovascular organic growth in fiscal 2027?
- A Kalshi cota Above 10% em 41% em 4 de setembro de 2026.
- Quando Medtronic cardiovascular organic growth in fiscal 2027 é resolvido?
- Medtronic cardiovascular organic growth in fiscal 2027 deverá ser resolvido em 31 de agosto de 2027.
- Como Medtronic cardiovascular organic growth in fiscal 2027 é liquidado?
- A Kalshi liquida este mercado da seguinte forma: If Medtronic plc reports Above 6% cardiovascular organic revenue growth in fiscal 2027, then the market resolves to Yes.
